Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001415889-25-010207·RA CAPITAL MANAGEMENT, L.P.
Schedule 13G ownership disclosure
SUTRO BIOPHARMA INC
Common Stock, $0.001 par value per share · CUSIP: 869367102
Event date: 2025-03-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 4,434,637.00 · Class: 5.3%
- Peter Kolchinsky
Shares: 4,434,637.00 · Class: 5.3%
- Rajeev Shah
Shares: 4,434,637.00 · Class: 5.3%
- RA Capital Healthcare Fund, L.P.
Shares: 4,434,637.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-010207
- Form type
- SCHEDULE 13G
- Filer
- RA CAPITAL MANAGEMENT, L.P.
- CIK
- CIK 1346824
- Filed
- Apr 04, 2025
- Reporting period
- Mar 28, 2025
- Description
- Schedule 13G beneficial ownership